Cargando…
Autophagy in liver diseases
Autophagy is the liver cell energy recycling system regulating a variety of homeostatic mechanisms. Damaged organelles, lipids and proteins are degraded in the lysosomes and their elements are re-used by the cell. Investigations on autophagy have led to the award of two Nobel Prizes and a health of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856864/ https://www.ncbi.nlm.nih.gov/pubmed/33584986 http://dx.doi.org/10.4254/wjh.v13.i1.6 |
_version_ | 1783646329416712192 |
---|---|
author | Kouroumalis, Elias Voumvouraki, Argryro Augoustaki, Aikaterini Samonakis, Dimitrios N |
author_facet | Kouroumalis, Elias Voumvouraki, Argryro Augoustaki, Aikaterini Samonakis, Dimitrios N |
author_sort | Kouroumalis, Elias |
collection | PubMed |
description | Autophagy is the liver cell energy recycling system regulating a variety of homeostatic mechanisms. Damaged organelles, lipids and proteins are degraded in the lysosomes and their elements are re-used by the cell. Investigations on autophagy have led to the award of two Nobel Prizes and a health of important reports. In this review we describe the fundamental functions of autophagy in the liver including new data on the regulation of autophagy. Moreover we emphasize the fact that autophagy acts like a two edge sword in many occasions with the most prominent paradigm being its involvement in the initiation and progress of hepatocellular carcinoma. We also focused to the implication of autophagy and its specialized forms of lipophagy and mitophagy in the pathogenesis of various liver diseases. We analyzed autophagy not only in well studied diseases, like alcoholic and nonalcoholic fatty liver and liver fibrosis but also in viral hepatitis, biliary diseases, autoimmune hepatitis and rare diseases including inherited metabolic diseases and also acetaminophene hepatotoxicity. We also stressed the different consequences that activation or impairment of autophagy may have in hepatocytes as opposed to Kupffer cells, sinusoidal endothelial cells or hepatic stellate cells. Finally, we analyzed the limited clinical data compared to the extensive experimental evidence and the possible future therapeutic interventions based on autophagy manipulation. |
format | Online Article Text |
id | pubmed-7856864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-78568642021-02-11 Autophagy in liver diseases Kouroumalis, Elias Voumvouraki, Argryro Augoustaki, Aikaterini Samonakis, Dimitrios N World J Hepatol Review Autophagy is the liver cell energy recycling system regulating a variety of homeostatic mechanisms. Damaged organelles, lipids and proteins are degraded in the lysosomes and their elements are re-used by the cell. Investigations on autophagy have led to the award of two Nobel Prizes and a health of important reports. In this review we describe the fundamental functions of autophagy in the liver including new data on the regulation of autophagy. Moreover we emphasize the fact that autophagy acts like a two edge sword in many occasions with the most prominent paradigm being its involvement in the initiation and progress of hepatocellular carcinoma. We also focused to the implication of autophagy and its specialized forms of lipophagy and mitophagy in the pathogenesis of various liver diseases. We analyzed autophagy not only in well studied diseases, like alcoholic and nonalcoholic fatty liver and liver fibrosis but also in viral hepatitis, biliary diseases, autoimmune hepatitis and rare diseases including inherited metabolic diseases and also acetaminophene hepatotoxicity. We also stressed the different consequences that activation or impairment of autophagy may have in hepatocytes as opposed to Kupffer cells, sinusoidal endothelial cells or hepatic stellate cells. Finally, we analyzed the limited clinical data compared to the extensive experimental evidence and the possible future therapeutic interventions based on autophagy manipulation. Baishideng Publishing Group Inc 2021-01-27 2021-01-27 /pmc/articles/PMC7856864/ /pubmed/33584986 http://dx.doi.org/10.4254/wjh.v13.i1.6 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Review Kouroumalis, Elias Voumvouraki, Argryro Augoustaki, Aikaterini Samonakis, Dimitrios N Autophagy in liver diseases |
title | Autophagy in liver diseases |
title_full | Autophagy in liver diseases |
title_fullStr | Autophagy in liver diseases |
title_full_unstemmed | Autophagy in liver diseases |
title_short | Autophagy in liver diseases |
title_sort | autophagy in liver diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856864/ https://www.ncbi.nlm.nih.gov/pubmed/33584986 http://dx.doi.org/10.4254/wjh.v13.i1.6 |
work_keys_str_mv | AT kouroumaliselias autophagyinliverdiseases AT voumvourakiargryro autophagyinliverdiseases AT augoustakiaikaterini autophagyinliverdiseases AT samonakisdimitriosn autophagyinliverdiseases |